Abstract
Purpose:
Evaluation of safety, efficacy, and patient satisfaction after PresbyMAX surgery
Methods
In private clinical practice, twenty-five presbyopic patients (28% males, 72% females), the average age is 40.72 ± 3.14. The dominant eye was fully corrected for distance vision; the non-dominant eye was corrected using central PresbyMAX monocular mode. Binocular uncorrected distance visual acuity (BUDVA), near visual acuity (BUNVA), and intermediate visual acuity (BUIVA) were monitored at 1 week, 1 month, and 3 months after surgery.
Result:
In this study, The mean Preoperative spherical equivalent was -3,27 ± 1,16. The mean Preoperative visual acuity was 1 ± 0,02. The BUDVA at 1 month postoperatively was 0,11 ± 0,09, the BUNVA was 1,96 ± 0,35, and BUDVA was equal to or better than 20/25 and 20/32 in all patients, 64% and 96%, respectively. Near vision J2 or better was achieved at 96%. Only 2 patients (8%) felt passable after surgery. The main unpleasant symptoms were blurred vision and glare.
Conclusions:
PresbyMAX monocular presbyopia correction combined with standard monocular LASIK in the other eye is a safe and acceptable procedure in older patients with refractive error.